# Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

> **NCT05626309** · NA · UNKNOWN · sponsor: **Jie Li** · enrollment: 310 (estimated)

## Conditions studied

- Esophagus Cancer

## Interventions

- **DRUG:** Qizhu Yuling Prescription
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05626309
- **Lead sponsor:** Jie Li
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2022-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626309, "Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05626309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*